Antonio
Antela López
Hospital Xeral Calde
Lugo, EspañaPublications in collaboration with researchers from Hospital Xeral Calde (7)
2018
-
Real world patient-reported outcomes in HIV-infected adults switching to EVIPLERA®, because of a previous intolerance to cART. PRO-STR study
Current HIV Research, Vol. 16, Núm. 6, pp. 425-435
2012
-
Switching to raltegravir in virologically suppressed in HIV-1-infected patients: A retrospective, multicenter, descriptive study
Current HIV Research, Vol. 10, Núm. 8, pp. 673-678
2010
-
El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infeccin por VIH-1
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 9, pp. 615-620
-
Liver toxicity after switching or simplifying to nevirapine-based therapy is not related to cd4 cell counts: Results of the TOSCANA study
HIV Clinical Trials, Vol. 11, Núm. 1, pp. 11-17
2009
-
(Enfermedades Infecciosas y Microbiologia Clinica (2009) 27, 4, (222-235))
Enfermedades Infecciosas y Microbiologia Clinica
-
The Spanish HIV BioBank: A model of cooperative HIV research
Retrovirology, Vol. 6
2006
-
Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir
AIDS, Vol. 20, Núm. 10, pp. 1407-1414